Baidu
map

类风湿关节炎中西医结合医疗质量控制指标专家共识(2021年版)

2021-02-20 中日友好医院学报.2021.35(1):12-15.

中西医结合治疗类风湿关节炎(RA)效果良好,目前被广泛应用,但由于部分地区对于RA 的临床管理尚不够规范,我国RA 治疗的现状仍不容乐观。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科

中文标题:

类风湿关节炎中西医结合医疗质量控制指标专家共识(2021年版)

发布机构:

发布日期:

2021-02-20

简要介绍:

中西医结合治疗类风湿关节炎(RA)效果良好,目前被广泛应用,但由于部分地区对于RA 的临床管理尚不够规范,我国RA 治疗的现状仍不容乐观。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科牵头,以北京中西医结合学会风湿病分会为依托,采用德尔菲法制定了《类风湿关节炎中西医结合医疗质量控制指标》专家共识(北京中西医结合学会标准化专家共识备案号:2021Z031A1),共10 个条目,包括RA 患者住院期间需评估的内容及治疗达标率、随访等医疗质量控制指标。本共识的制定为我国RA 中西医结合医疗质量控制提供参考,将有助于改善RA 诊治现状。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=类风湿关节炎中西医结合医疗质量控制指标专家共识_2021年版_陶庆文.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0437d1c0020e3aa3, title=类风湿关节炎中西医结合医疗质量控制指标专家共识(2021年版), enTitle=, guiderFrom=中日友好医院学报.2021.35(1):12-15., authorId=0, author=, summary=中西医结合治疗类风湿关节炎(RA)效果良好,目前被广泛应用,但由于部分地区对于RA 的临床管理尚不够规范,我国RA 治疗的现状仍不容乐观。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科, cover=https://img.medsci.cn/2021325/1616686183000_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Feb 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>中西医结合治疗类风湿关节炎(RA)效果良好,目前被广泛应用,但由于部分地区对于RA 的临床管理尚不够规范,我国RA 治疗的现状仍不容乐观。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科牵头,以北京中西医结合学会风湿病分会为依托,采用德尔菲法制定了《类风湿关节炎中西医结合医疗质量控制指标》专家共识(北京中西医结合学会标准化专家共识备案号:2021Z031A1),共10 个条目,包括RA 患者住院期间需评估的内容及治疗达标率、随访等医疗质量控制指标。本共识的制定为我国RA 中西医结合医疗质量控制提供参考,将有助于改善RA 诊治现状。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=457, tagName=类风湿关节炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=457, guiderKeyword=类风湿关节炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10428, appHits=506, showAppHits=0, pcHits=905, showPcHits=9919, likes=2, shares=33, comments=23, approvalStatus=1, publishedTime=Thu Mar 25 23:31:11 CST 2021, publishedTimeString=2021-02-20, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 25 23:29:48 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 09:08:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=类风湿关节炎中西医结合医疗质量控制指标专家共识_2021年版_陶庆文.pdf)])
类风湿关节炎中西医结合医疗质量控制指标专家共识_2021年版_陶庆文.pdf
下载请点击:
评论区 (22)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1213157, encodeId=191c121315e4f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:03:16 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212650, encodeId=349712126503a, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:38:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201103, encodeId=d3881201103f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7d5571811, createdName=ms1000001987057106, createdTime=Thu Mar 10 00:54:45 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197489, encodeId=4aa4119e48934, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77d93729410, createdName=1355517cm30暂无昵称, createdTime=Sat Feb 26 15:16:19 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190919, encodeId=db0e119091929, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhXVnLiaY10nQw4uFalm8mcrN5q5QHja4tmhrJ7TqomRQOous5WVLkMyqNn5IVQdBdOZmp26UUW6Q/132, createdBy=0aec5262425, createdName=骑迹2018, createdTime=Tue Feb 08 08:36:42 CST 2022, time=2022-02-08, status=1, ipAttribution=)]
    2022-04-21 135434d0m28暂无昵称

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1213157, encodeId=191c121315e4f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:03:16 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212650, encodeId=349712126503a, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:38:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201103, encodeId=d3881201103f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7d5571811, createdName=ms1000001987057106, createdTime=Thu Mar 10 00:54:45 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197489, encodeId=4aa4119e48934, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77d93729410, createdName=1355517cm30暂无昵称, createdTime=Sat Feb 26 15:16:19 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190919, encodeId=db0e119091929, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhXVnLiaY10nQw4uFalm8mcrN5q5QHja4tmhrJ7TqomRQOous5WVLkMyqNn5IVQdBdOZmp26UUW6Q/132, createdBy=0aec5262425, createdName=骑迹2018, createdTime=Tue Feb 08 08:36:42 CST 2022, time=2022-02-08, status=1, ipAttribution=)]
    2022-04-19 qqnded

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1213157, encodeId=191c121315e4f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:03:16 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212650, encodeId=349712126503a, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:38:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201103, encodeId=d3881201103f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7d5571811, createdName=ms1000001987057106, createdTime=Thu Mar 10 00:54:45 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197489, encodeId=4aa4119e48934, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77d93729410, createdName=1355517cm30暂无昵称, createdTime=Sat Feb 26 15:16:19 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190919, encodeId=db0e119091929, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhXVnLiaY10nQw4uFalm8mcrN5q5QHja4tmhrJ7TqomRQOous5WVLkMyqNn5IVQdBdOZmp26UUW6Q/132, createdBy=0aec5262425, createdName=骑迹2018, createdTime=Tue Feb 08 08:36:42 CST 2022, time=2022-02-08, status=1, ipAttribution=)]
    2022-03-10 ms1000001987057106

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1213157, encodeId=191c121315e4f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:03:16 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212650, encodeId=349712126503a, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:38:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201103, encodeId=d3881201103f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7d5571811, createdName=ms1000001987057106, createdTime=Thu Mar 10 00:54:45 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197489, encodeId=4aa4119e48934, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77d93729410, createdName=1355517cm30暂无昵称, createdTime=Sat Feb 26 15:16:19 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190919, encodeId=db0e119091929, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhXVnLiaY10nQw4uFalm8mcrN5q5QHja4tmhrJ7TqomRQOous5WVLkMyqNn5IVQdBdOZmp26UUW6Q/132, createdBy=0aec5262425, createdName=骑迹2018, createdTime=Tue Feb 08 08:36:42 CST 2022, time=2022-02-08, status=1, ipAttribution=)]
    2022-02-26 1355517cm30暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1213157, encodeId=191c121315e4f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67df3725267, createdName=135434d0m28暂无昵称, createdTime=Thu Apr 21 15:03:16 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212650, encodeId=349712126503a, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:38:57 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201103, encodeId=d3881201103f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e7d5571811, createdName=ms1000001987057106, createdTime=Thu Mar 10 00:54:45 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197489, encodeId=4aa4119e48934, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77d93729410, createdName=1355517cm30暂无昵称, createdTime=Sat Feb 26 15:16:19 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190919, encodeId=db0e119091929, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLhXVnLiaY10nQw4uFalm8mcrN5q5QHja4tmhrJ7TqomRQOous5WVLkMyqNn5IVQdBdOZmp26UUW6Q/132, createdBy=0aec5262425, createdName=骑迹2018, createdTime=Tue Feb 08 08:36:42 CST 2022, time=2022-02-08, status=1, ipAttribution=)]
    2022-02-08 骑迹2018

    0

拓展阅读

2010 BSR/BHPR 类风湿关节炎中抗肿瘤坏死因子疗法的安全指引

英国风湿病学会(BSR,British Society for Rheumatology) · 2010-01-01

2010版类风湿关节炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-04-01

2010 依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议

中国风湿免疫科相关专家小组(统称) · 2010-06-30

2010 ACR/EULAR 类风湿关节炎分类标准

美国风湿病学会(ACR,American College of Rheumatology) · 2010-09-01

2011 BSR/BHPR 指南:使用利妥昔单抗治疗类风湿关节炎

英国风湿病学会(BSR,British Society for Rheumatology) · 2011-01-01

2011SIGN 苏格兰国家类风湿关节炎早期治疗临床指南

苏格兰校际指南网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2011-01-01

Baidu
map
Baidu
map
Baidu
map